SM
Siddharth Mittal
About Siddharth Mittal
Data last updated:
Siddharth Mittal is a Managing Director at Biocon Limited (since 2019), Whole-Time Director at Biocon Pharma Limited (since 2020) and Director at Biocon Biosphere Limited (since 2019), and holds 1 more current directorship. The companies operate in Pharma, Education and Information Technology. The 4 current companies with reported revenue have a combined latest revenue of ₹17,476 Cr; the largest is Biocon Limited at ₹16,470 Cr (FY 2025). Earlier, Siddharth Mittal was a Director at Summit It Solutions Private Limited (2011–2013) and Cfo at Biocon Biologics Limited (2019) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 01 Dec 2019 | 1978 | ₹16,470 Cr (FY 2025) | Active | |
| Whole-Time Director | 23 Jan 2020 | 2014 | ₹982 Cr (FY 2025) | Active | |
| Director | 24 Dec 2019 | 2019 | ₹13.00 Cr (FY 2025) | Active | |
| Director | 21 Jan 2021 | 2013 | ₹10.28 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Feb 2011 | 2008 | ₹95.60 Cr (FY 2024) | Active | |
| Cfo | 01 Mar 2019 | 2016 | ₹10,144 Cr (FY 2025) | Active | |
| Director | 08 Sep 2010 | 1996 | Amalgamated | ||
| Director | 08 Sep 2010 | 1997 | Amalgamated | ||
| Director | 18 Mar 2021 | 2021 | ₹56.53 Cr (FY 2023) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Siddharth Mittal
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Siddharth Mittal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Siddharth Mittal
Siddharth Mittal currently holds 4 directorships: Biocon Limited (Managing Director, since 01 Dec 2019, revenue ₹16,470 Cr (FY 2025)); Biocon Pharma Limited (Whole-Time Director, since 23 Jan 2020, revenue ₹982 Cr (FY 2025)); Biocon Biosphere Limited (Director, since 24 Dec 2019, revenue ₹13.00 Cr (FY 2025)); Biocon Academy (Director, since 21 Jan 2021, revenue ₹10.28 Cr (FY 2025)).
Siddharth Mittal was first appointed on 08 Sep 2010 as Director at Coreobjects India Private Limited. The most recent appointment on record is 18 Mar 2021 at Biofusion Therapeutics Limited.
The 4 current companies of Siddharth Mittal that report revenue have a combined latest revenue of ₹17,476 Cr: Biocon Limited ₹16,470 Cr (FY 2025); Biocon Pharma Limited ₹982 Cr (FY 2025); Biocon Biosphere Limited ₹13.00 Cr (FY 2025); Biocon Academy ₹10.28 Cr (FY 2025).
Siddharth Mittal held 5 earlier board appointments: Summit It Solutions Private Limited (Director, 01 Feb 2011 to 16 Jul 2013); Biocon Biologics Limited (Cfo, 01 Mar 2019 to 23 Oct 2019); Coreobjects India Private Limited (Director, from 08 Sep 2010); Jopasana Software & Systems Private Limited (Director, from 08 Sep 2010); Biofusion Therapeutics Limited (Director, from 18 Mar 2021).
The current boards of Siddharth Mittal's companies include Arun Suresh Chandavarkar (Biocon Limited), Atul Dhawan (Biocon Limited), Daniel Mark Bradbury (Biocon Limited), Eric Vivek Mazumdar (Biocon Limited), Kedar Upadhye (Biocon Limited), Kiran Mazumdar Shaw (Biocon Limited), among others.